Using Genomic Sequencing to Explain an Exceptional Response to Therapy in a Malignant Phyllodes Tumor
Ciara Conduit, Stephen Luen, Huiling Xu, David Byrne, Stephen Fox, Jayesh Desai, Anne Hamilton
JCO Precision Oncology | LIPPINCOTT WILLIAMS & WILKINS | Published : 2020
The patient described has provided her informed consent for publication of her clinical course, including presentation, progress, and relevant results, including imaging and genomic details. Tumor genomic sequencing using the TruSight Oncology 500 Assay was achieved via enrolment in the PRECISION program funded by the Victorian Comprehensive Cancer Centre.